查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1196945

全球乳房固定術市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Global Mastopexy Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

所研究的乳房固定術市場預計在預測期內（2022 年至 2027 年）以 5.7% 的複合年增長率增長。

隨著新型冠狀病毒肺炎 (COVID-19) 大流行的發展，燒蝕換膚激光、微針和皮膚外科手術的安全性似乎也受到了損害。 此外，經濟放緩和可自由支配支出的下降對顧客造成了真正的限制，因為他們迴避昂貴的美容治療。 根據 2020 年整形外科統計報告，2020 年共有 87,051 名患者接受了乳房固定術。 因此，預計全球人口對美容手術的偏好將推動疫情期間的市場增長。

據估計，女性老年人口的增加和整容手術需求的增加將推動預測期內的市場增長。 不斷上升的醫療成本和不斷增長的門診手術需求正在推動市場增長。 此外，增加產品發布也有望促進市場增長。 例如，2021年5月，GC Aesthetics Inc.推出了下一代乳房植入物“PERLE”。 PERLE 是高度創新的光滑乳房植入物系列，採用專有表面技術、GCA 行業領先的凝膠技術和增強的安全功能，鞏固了 GCA 長期成功的安全記錄。 2021 年 2 月，高德美 (Galderma) 獲得美國食品藥品監督管理局 (Food and Drug Administration) 批准 RESTYLANE DEFYNE 用於增強和矯正成人輕度至中度頜骨退縮。 然而，據估計，在預測期內，乳房固定術的高成本以及隨後的手術並發症等因素將抑制市場增長。

乳房固定術市場趨勢

預計在預測期內全乳房固定術將主導市場

就技術而言，完整的乳房固定術細分市場在收入方面佔據了大部分市場份額。 完全性乳房固定術主要針對老年女性乳房下垂的情況進行。 它也適用於接受過乳房固定術或乳房切除術的乳腺癌患者。 在這種手術中，外科醫生往往會去除癌組織，這可能會導致乳房重建手術。 據美國癌症協會估計，2022 年美國將診斷出 287,850 例浸潤性乳腺癌新病例。 因此，乳腺癌的高發病率可能會推動市場增長。

Mastopexy 在有或沒有植入物的情況下都能恢復胸部的體積和豐滿度。 根據美學協會 2022 年 4 月發表的文章，2021 年乳房手術的年度統計數據與 2020 年相比增長了 48%。 2021 年進行了 365,000 次乳房植入手術。 因此，越來越多的乳房植入物將有助於在預測期內推動對全乳房固定術的需求。

預計在預測期內北美將呈現出眾的增長

北美地區佔 2021 年市場收入的大部分份額，預計在預測期內將繼續如此。 推動該地區增長的因素包括女性對整容手術的需求不斷增長以及可支配收入的增加。 根據美國骨科醫師學會的數據，自 2000 年以來，隨著正在開發的新的和富有想像力的塑造身體的方法，微創整容手術增加了近 200%。 豐胸手術在北美地區名列前茅。 乳腺癌是美國主要的癌症類型之一。 根據 2022 年 1 月更新的 Breastcancer.org，大約八分之一的女性（約 13%）將在其一生中患上浸潤性乳腺癌。 預計這種女性乳腺癌發病率將推動市場增長。

在美國，女性對整容手術的需求非常高，這是該地區乳房固定術市場增長的關鍵因素之一。 例如，美國整形外科學院 2020 年 5 月的一份報告將隆胸列為 2020 年美國進行的前五名整容手術之一。 此外，2020 年實施的乳房植入物總數為 193,073 例。 預計北美乳腺癌患病率的增加也將補充該地區乳房固定術市場的增長。 根據 GLOBOCAN 2020 報告，2020 年美國、加拿大和墨西哥的乳腺癌新發病例數分別為 253,465 例、28,026 例和 29,929 例。 因此，預計在預測期內，北美將在乳房固定術市場中佔據很大的市場份額。

Mastopexy 市場競爭對手分析

乳房固定術市場競爭適中，由幾家大型企業組成。 目前主導市場的公司包括 Allergan、Sientra, Inc、Ideal Implant Incorporated、Johnson & Johnson、Establishment Labs、POLYTECH Health & Aesthetics GmbH、RTI Surgical, Inc、Groupe Sebin SAS、Integra LifeSciences 和 GC Aesthetics。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 越來越多地採用胸部提升術
    • 人們越來越傾向於強調外在美
    • 老年女性人口增加
    • 整容手術的上升趨勢
  • 市場製約因素
    • 這些程序的高成本
    • 術後並發症
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按技術
    • 貝內利電梯
    • 新月形隆胸
    • Benelli Lollipop 升降機
    • 完整的乳房固定術
  • 通過使用
    • 專科診所
    • 醫院
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 意大利
      • 其他歐洲地區
    • 亞太地區
      • 印度
      • 日本
      • 中國
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Allergan
    • Mentor Word Wide LLC
    • GC Aesthetics
    • Lipoclastic
    • Cynosure
    • Polytech Health & Aesthetics
    • Sientra
    • Galderma
    • Lumenis
    • Solta Medical
    • Syneron Medical

第7章 市場機會今後動向

簡介目錄
Product Code: 91279

The Mastopexy market studied is expected to grow with an estimated CAGR of 5.7% over the forecast period (2022-2027).

As the COVID-19 pandemic progressed with new strains, the safety of ablative resurfacing lasers, micro-needling, and dermatological surgery procedures also seemed to be unsafe. Additionally, the slowing economy and reduced discretionary spending discourage customers from undergoing expensive cosmetic treatments, thus imposing practical restrictions. The Plastic Surgery Statistics Report from the year, 2020 states that a total population of 87,051 patients underwent mastopexy surgery in 2020. Therefore the preference for aesthetic surgeries among the global population is expected to drive the growth of the market during the pandemic period.

The rising female geriatric population and growing demands for aesthetic procedures are estimated to drive market growth during the forecast period. Increased healthcare expenditures and the growing demands for outpatient surgeries are boosting market growth. Additionally, the increasing product launches are expected to contribute to the growth of the market. For, Instance, In May 2021, GC Aesthetics Inc. launched its next generation of breast implants, PERLE. PERLE is a highly innovative line of smooth breast implants that features proprietary surface technology, GCA's industry-leading gel technology, and an enhanced version of the safety features that have underpinned GCA's long-term excellent safety record. In February 2021, Galderma received the approval of RESTYLANE DEFYNE by the United States Food and Drug Administration for the augmentation and correction of mild to moderate chin retrusion for adults. However, factors such as the high cost of mastopexy followed by complications of the surgery are estimated to restrain the market growth during the forecast period.

Mastopexy Market Trends

Full Mastopexy Segment is Expected to Dominate the Market over the Forecast Period

Based on technique, the full mastopexy segment held a majority of the market share in terms of revenue. The full mastopexy procedure is performed in cases of breast sagginess, mainly observed in older women. Mastopexy is also performed in breast cancer patients who undergo mastectomy and lumpectomy. During the procedure, the surgeons tend to remove cancerous tissues, which can lead to breast reconstruction surgery. According to the American Cancer Society, it was estimated that 287,850 new cases of invasive breast cancer would be diagnosed in the United States in 2022. The high incidence of breast cancer can thus boost market growth.

The mastopexy restores the volume and fullness of the breasts with or without the use of implants. As per the Aesthetic Society article published in April 2022, the annual statistics of breast surgical procedures in 2021, accounted for 48% growth compared to 2020. There were 365,000 breast augmentations performed in 2021. Thus, the increase in the number of breast augmentations will help to propel the demand for full mastopexy during the forecast period.

North America is projected to have a Prominent Growth Rate over the Forecast Period

North America region is the majority share contributor to the market revenue in 2021 and is expected to continue during the forecast period. Some of the factors driving regional growth include the rising demand for aesthetic procedures among women and increased disposable income. According to the American Society of Plastic Surgeons figures, new and imaginative ways to shape the bodies are been developed, with minimally invasive cosmetic operations increasing nearly 200 percent since 2000. Breast enhancement is one of the top cosmetic surgical procedures performed in the North American region. In the United States, breast cancer is one of the leading cancer types. According to Breastcancer.org, updated in January 2022, about 1 in 8 women (about 13%) will develop invasive breast cancer over their lifetime. Such prevalence of breast cancer among women is expected to drive the growth of the market.

The demand for cosmetic surgeries and procedures in the United States is very high among women, which is one of the significant factors for the growth of the mastopexy market in the region. For instance, according to the American Society of Plastic Surgeons report published in May 2020, breast augmentation was one of the top five cosmetic surgical procedures performed in 2020 in the United States. Moreover, the total number was 193,073 breast augmentation procedures in 2020. In addition, the increasing prevalence of breast cancer in North America will also complement the growth of the mastopexy market in the region. As per the GLOBOCAN 2020 report, the new breast cancer cases in the United States, Canada, and Mexico were 253,465, 28,026, and 29,929, respectively, in 2020. Therefore, North America is expected to hold a significant market share in the Mastopexy market during the forecast period.

Mastopexy Market Competitor Analysis

The mastopexy market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Allergan, Sientra, Inc,Ideal Implant Incorporated, Johnson & Johnson, Establishment Labs, POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebin SAS, Integra LifeSciences, and GC Aesthetics.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definitions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing adoption of breast lifting procedures
    • 4.2.2 Growing prominence on physical appearance
    • 4.2.3 Rising female geriatric population
    • 4.2.4 Rising trend of aesthetic procedures
  • 4.3 Market Restraints
    • 4.3.1 High cost of these procedures
    • 4.3.2 Post-surgery complications
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technique
    • 5.1.1 Benelli Lift
    • 5.1.2 Crescent Breast Lift
    • 5.1.3 Benelli-Lollipop Lift
    • 5.1.4 Full Mastopexy
  • 5.2 By End use
    • 5.2.1 Speciality Clinics
    • 5.2.2 Hospitals
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 United Kingdom
      • 5.3.2.2 Germany
      • 5.3.2.3 France
      • 5.3.2.4 Spain
      • 5.3.2.5 Italy
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 India
      • 5.3.3.2 Japan
      • 5.3.3.3 China
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of the Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan
    • 6.1.2 Mentor Word Wide LLC
    • 6.1.3 GC Aesthetics
    • 6.1.4 Lipoclastic
    • 6.1.5 Cynosure
    • 6.1.6 Polytech Health & Aesthetics
    • 6.1.7 Sientra
    • 6.1.8 Galderma
    • 6.1.9 Lumenis
    • 6.1.10 Solta Medical
    • 6.1.11 Syneron Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS